Related Experiment Videos
A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans
K Yoshida1, K Furihata, S Takeda
1Department of Medicine (Neurology), Shinshu University School of Medicine, Matsumoto, Japan.
Insights
A mutation in the ceruloplasmin (Cp) gene causes aceruloplasminemia, leading to iron overload in the brain, liver, and pancreas. This genetic defect results in neurological and metabolic disorders, including ataxia and diabetes mellitus.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Background:
- Aceruloplasminemia is a rare genetic disorder characterized by iron accumulation in various organs.
- Affected individuals often present with neurological symptoms like ataxia and movement disorders, alongside diabetes mellitus.
Purpose of the Study:
- To identify the genetic cause of aceruloplasminemia in a Japanese family.
- To elucidate the molecular mechanism underlying the disease pathology.
Main Methods:
- Genetic analysis of the ceruloplasmin (Cp) gene in affected family members.
- Post-mortem examination of the proband to assess iron deposition.
- Molecular analysis of gene splicing and protein truncation.
Main Results:
- A specific G to A mutation at the splice acceptor site of the Cp gene was identified.
- This mutation leads to defective splicing and a premature termination codon at amino acid 991.
- Post-mortem findings confirmed excessive iron deposition in the brain, liver, and pancreas of the proband.
Conclusions:
- The identified mutation in the ceruloplasmin (Cp) gene is the causative factor for aceruloplasminemia in this family.
- The mutation results in a truncated Cp protein, leading to systemic iron overload (hemosiderosis).
- This study links Cp gene mutations to neurological and metabolic manifestations of aceruloplasminemia.
Abstract:
We identified a mutation in the ceruloplasmin (Cp) gene in a Japanese family with aceruloplasminemia, some of whose members showed extrapyramidal disorders, cerebellar ataxia, and diabetes mellitus. A post-mortem study of the proband revealed excessive iron deposition mainly in the brain, liver and pancreas. The G to A transition at the splice acceptor site introduces a premature termination codon at the amino acid position 991 by defective splicing, thereby truncating the carboxyl terminus of Cp in affected individuals. We conclude that the mutation in the Cp gene is associated with systemic hemosiderosis in humans.